Track Real Time Price

According to ChemAnalyst , The global Bupropion Prices recorded a generally firm trend during the second quarter of 2026, with North America, APAC, and Europe experiencing quarter-over-quarter increases. Rising production costs, fluctuations in feedstock markets, pharmaceutical-sector activity, and disruptions across chemical supply chains remained the principal factors shaping price movements. Bupropion is an important pharmaceutical active ingredient used primarily in therapies associated with depression and smoking cessation. Consequently, its pricing is influenced not only by pharmaceutical demand but also by the availability and cost of chemical intermediates, energy, transportation, and manufacturing inputs. During Q2 2026, producers in major markets faced higher upstream cost pressure. However, the direction of feedstock prices varied during the quarter. In North America, naphtha and crude oil-related costs surged early in the quarter before easing toward June, while Asian prod...

According to ChemAnalyst , The Bupropion prices witnessed a generally positive pricing trend across major global regions during the second quarter of 2026 , supported by higher manufacturing costs, inflationary pressures, and fluctuating feedstock markets. Bupropion, a widely prescribed antidepressant and smoking cessation medication, continued to experience steady demand from pharmaceutical manufacturers and healthcare providers despite varying economic conditions across North America, Asia-Pacific, and Europe. Throughout Q2 2026, producers faced rising operational expenses driven by higher producer inflation, energy costs, transportation expenses, and volatile feedstock prices. Although some raw material costs eased toward the end of June, the overall quarterly pricing trend remained upward because manufacturers continued to absorb elevated production costs accumulated during April and May. Global Bupropion Market Overview The global Bupropion market experienced balanced supply-dema...

According to ChemAnalyst , The global Bupropion prices experienced a notable upward trend during the first quarter of 2026, supported by rising production expenses, increasing feedstock costs, stable pharmaceutical demand, and evolving economic conditions across major manufacturing regions. Bupropion, a widely prescribed antidepressant and smoking cessation medication, remains a critical active pharmaceutical ingredient (API) in the healthcare industry. As demand for mental health treatments continues to expand worldwide, manufacturers and suppliers have faced mounting cost pressures, resulting in higher pricing across North America, Asia-Pacific, and Europe. Several macroeconomic factors influenced the Bupropion price trend during Q1 2026, including inflationary pressures, feedstock volatility, industrial production performance, transportation expenses, and changing consumer spending patterns. Pharmaceutical companies also continued to adjust procurement strategies to ensure uninte...

Bupropion Prices Witnessed Upward Momentum in Q1 2026 The global Bupropion market experienced a noticeable upward pricing trend during the first quarter of 2026. Rising feedstock costs, persistent inflationary pressures, and higher manufacturing expenses collectively influenced the Bupropion Price Index across major regions including North America, Asia Pacific, and Europe. Market participants observed stronger procurement activity from pharmaceutical manufacturers while production costs remained elevated due to increases in chemical intermediates and utility expenditures. Bupropion, widely used in antidepressant and smoking cessation medications, remained under steady demand from the pharmaceutical sector. The quarter ending March 2026 highlighted how raw material fluctuations and regional economic indicators significantly impacted pricing behavior across global markets. In addition, producers faced increased operational burdens associated with transportation, labor, and energy expen...